CRVO Earnings

Quarterly EPS
$-0.55
Q3 2024
$-0.77
Q4 2024
$-0.56
Q1 2025
$-0.70
Q2 2025
$-0.84
Q3 2025
$-0.87
Q4 2025
$-0.86
Q1 2026
$-0.64
Q2 2026
Latest RevenueN/A
Latest Net Income-6571656
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.640-6571656-100.0%+8.6%
Q1 2026-$0.860-7964158-100.0%-53.6%
Q4 2025-$0.878.7K-8087290-99.6%-13.0%
Q3 2025-$0.84322.6K-7726639-83.4%-52.7%
Q2 2025-$0.701.8M-6258404-46.6%-159.3%
Q1 2025-$0.561.9M-4894034-18.3%-36.6%
Q4 2024-$0.772.2M-6705914-13.2%-108.1%
Q3 2024-$0.551.9M-4753541+27.1%-184.6%
Q2 2024-$0.273.3M-2316905
Q1 2024-$0.412.3M-2514335
Q4 2023-$0.372.5M-2362398
Q3 2023$0.651.5M2.2M
CervoMed (CRVO) — Earnings